House passes bill to lift stem cell funding restrictions ( Washington D.C. - The United States ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

House passes bill to lift stem cell funding restrictions

Washington, D.C. - The United States House of Representatives, for the second time in the past two years, has passed a measure that would lift President Bush's restrictions on federal funding for human embryonic stem cell research.

But the vote of 253 to 174 is not enough to override a promised pre......

Full article >>>

Source:wistechnology.com By WTN News 01/11/07

Page: 1 2
Related biology technology :

1. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
2. House may vote soon to relax stem-cell restrictions
3. State faces revenue drop as federal Internet tax ban passes House
4. CPM Helps Physicians Group Retain Patients with New Kind of House Call
5. QBIs PreserveX product passes initial test
6. EraGen diagnostic passes UW tests, could quickly detect bird flu
7. Cloning ban passes Assembly, Doyle pledges veto
8. As HIPAA deadline passes even the unprepared are safe for now
9. Congress passes bill to ease researchers collaboration worries
10. Tech Council passes E-Learning efforts for Northern Wisconsin
11. MyWeather-powered alerting system surpasses 165,000 downloads

Post Your Comments:

Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6 Alberta companies delivering new products to the health & medical marketplace 2 JourneyLite of Houston Now Offering Sleeve Gastrectomy 2 VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2 VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3 VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4

[0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Alberta companies delivering new products to the health & medical marketplace [0] JourneyLite of Houston Now Offering Sleeve Gastrectomy [0] VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291

Other Biology Technology:Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2 Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3 Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R) 2 Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R) 3 Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 2 Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 3 Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 4

Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care

Breaking Biology News(10 mins):IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 3 $2.4 million stimulus fuels effort to regenerate injured spinal cords 4 Fattah 3A Waiting Time is Over on Healthcare 56691 1 In Letter to President TPC Highlights Foundation Grants in Health 56686 1 In Letter to President TPC Highlights Foundation Grants in Health 56686 2 In Letter to President TPC Highlights Foundation Grants in Health 56686 3 Link found between common sexual infection and risk of aggressive prostate cancer 56681 1 Link found between common sexual infection and risk of aggressive prostate cancer 56681 2

[0] IgeaCare Solutions Inc. Emerges Under New Leadership and Funding [0] U of A's David Schindler confirms untold levels of oil sands pollution on the Athabasca [0] $2.4 million stimulus fuels effort to regenerate injured spinal cords

Other Biology News:Decoding effects of toxins on embryo development 2 $2.8 million for research into the impact of climate change on tundra wildlife 2 Pregnant women at risk for unnecessary operations due to misdiagnosis of appendicitis 2

Decoding effects of toxins on embryo development $2.8 million for research into the impact of climate change on tundra wildlife Pregnant women at risk for unnecessary operations due to misdiagnosis of appendicitis

Biology Products:

HERAfreeze -86C chest and upright freezers from Thermo Scientific Nar I from Promega Bsu36 I from Promega Enterokinase from bovine intestine from Sigma-Aldrich